(Q79722143)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17279454%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

A method to predict the metabolic effects of changes in insulin treatment in subgroups of a large population based patient cohort (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17279454%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17279454%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Marcus Osterbrand

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17279454%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Martin Fahlén

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17279454%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Anders Odén

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17279454%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

6 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17279454%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Epidemiology

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17279454%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17279454%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17279454%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

151-157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17279454%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10654-007-9107-4

25 December 2019

exact match

0 references

cites work

Near-normal urinary albumin concentrations predict progression to diabetic nephropathy in Type 1 diabetes mellitus

1 reference

12 December 2020

The utility of insulin glargine in the treatment of diabetes mellitus

1 reference

12 December 2020

Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin

1 reference

12 December 2020

Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo

1 reference

12 December 2020

The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial

1 reference

12 December 2020

Oral anticoagulation and risk of death: a medical record linkage study

1 reference

12 December 2020

Intravenous estrogens increase insulin clearance and action in postmenopausal women

1 reference

12 December 2020

A One-year, Randomised, Multicentre Trial Comparing Insulin Glargine with NPH Insulin in Combination with Oral Agents in Patients with Type 2 Diabetes

1 reference

12 December 2020

Risk factors for the development of diabetic retinopathy in Japanese type 2 diabetic patients

1 reference

12 December 2020

A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes

1 reference

12 December 2020

Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

1 reference

12 December 2020

Optimization of basal insulin delivery in Type 1 diabetes: a retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargine.

1 reference

12 December 2020

Health outcomes in type 2 diabetes.

1 reference

12 December 2020

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

1 reference

12 December 2020

Glargine versus NPH insulin: efficacy in comparison with insulin aspart in a basal bolus regimen in type 1 diabetes--the glargine and aspart study (GLASS) a randomised cross-over study.

1 reference

12 December 2020

Prognostic factors for successful insulin therapy in subjects with type 2 diabetes.

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

1 reference

12 December 2020

Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes

1 reference

12 December 2020

Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.

1 reference

12 December 2020

Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study

1 reference

12 December 2020

Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review

1 reference

12 December 2020

Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy

1 reference

12 December 2020

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

12 December 2020

IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study.

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial

1 reference

12 December 2020

Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine

1 reference

12 December 2020

Confounding by indication in epidemiologic studies of commonly used analgesics

1 reference

12 December 2020

Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin

1 reference

12 December 2020